Article
INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer
2 Sept 2022
Abstract excerpt
Inhibin subunit beta B (INHBB) is a potential prognostic biomarker for a variety of cancers. However, its role in gastric cancer (GC) remains elusive. The differential expression data of INHBB in tumor and normal tissues were extracted from several databases and genetic alterations of INHBB were assessed by cBioPortal. Kaplan-Meier analysis was used to evaluate the survival rate of patients with GC with INHBB and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
